Problem
You are Dr. John W. Jones, a biological research scientist employed by a pharmaceutical firm. You have recently developed a synthetic chemical useful for curing and preventing rubosen. Rubosen is a disease contracted by pregnant women. If not caught in the first four weeks of pregnancy, the disease causes serious brain, eye, and ear damage to the unborn child. Recently there has been an outbreak of rubosen in your state and several thousand women have contracted the disease. You have found, with volunteer patients, that your recently developed synthetic serum cures Rubosen in its early stages. Unfortunately, the serum is made from the juice of the Ugli orange which is a very rare fruit. Only a small quantity (approximately 4,000) of these oranges were produced last season. No additional Ugli oranges will be available until next season, which will be too late to cure the present rubosen victims.
You have demonstrated that your synthetic serum is in no way harmful to pregnant women. Consequently, there are no side effects. The Food and Drug Administration has approved of the production and distribution of the serum as a cure for rubosen. Unfortunately, the present outbreak was unexpected and your firm had not planned on having the compound serum available for six months. Your firm-holds the patent on the synthetic serum and it is expected to be a highly profitable product when it is generally available to the public.
You have recently been informed, on good evidence, that Mr. R.H. Cardoza, a South American fruit exporter, is in possession of 3,000 Ugli oranges in good condition. If you could obtain the juice of all 3,000, you would be able to both cure present victims and provide sufficient inoculation for the remaining pregnant women in the state. No other state currently has a rubosen threat.
You have recently been informed that Dr. P. W. Roland is also urgently seeking Ugli oranges and is also aware of Mr. Cardoza's possession of the 3,000 available. Dr. Roland is employed by a competing pharmaceutical firm. He has been working on biological warfare research for the past several years. There is a great deal of industrial espionage in the pharmaceutical industry. Over the past several years, Dr. Roland's firm and yours have sued each other for infringement of patent rights and espionage law violations several times.
You have been authorized by your firm to approach Mr. Cardoza to purchase the 3,000 Ugli oranges. To the best of your knowledge you are the only two bidding on these oranges. Your firm has authorized you to bid as high as $250,000 to obtain the juice of the 3,000 available oranges.
Before approaching Mr. Cardoza, you have decided to talk with Dr. Roland to influence him so that he will not prevent you from purchasing the oranges.
Before approaching Mr. Cardoza, you have decided to talk with Dr. Roland to influence him so that he will not prevent you from purchasing the oranges.
Thinking about the way of communication and negotiation, how should I (Dr. John) raise this topic with Dr. Rowland, what points should I bring up in the conversation?